Education
About Us
Working with TipRanks
Follow Us
SpectraCure AB (DE:2OK)
FRANKFURT:2OK
2OK Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.02 - €0.39
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.85M
Enterprise ValueN/A
Total Cash (Recent Filing)€18.27M
Total Debt (Recent Filing)kr5.14M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding97,131,610
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.55
Price to Sales (P/S)0.00
P/FCF Ratio-4.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
2OK FAQ
What was SpectraCure AB’s price range in the past 12 months?
SpectraCure AB lowest stock price was €0.02 and its highest was €0.39 in the past 12 months.
What is SpectraCure AB’s market cap?
SpectraCure AB’s market cap is €6.85M.
When is SpectraCure AB’s upcoming earnings report date?
SpectraCure AB’s upcoming earnings report date is Aug 21, 2025 which is in 99 days.
How were SpectraCure AB’s earnings last quarter?
SpectraCure AB released its earnings results on Feb 20, 2025. The company reported -€0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.004.
Is SpectraCure AB overvalued?
According to Wall Street analysts SpectraCure AB’s price is currently Overvalued.
Does SpectraCure AB pay dividends?
SpectraCure AB does not currently pay dividends.
What is SpectraCure AB’s EPS estimate?
SpectraCure AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SpectraCure AB have?
SpectraCure AB has 97,131,610 shares outstanding.
What happened to SpectraCure AB’s price movement after its last earnings report?
SpectraCure AB reported an EPS of -€0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of SpectraCure AB?
Currently, no hedge funds are holding shares in DE:2OK
---
Company Description
SpectraCure AB
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
---
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
Q-linea AB
―
Acarix AB
―
Scandinavian Real Heart AB
―
---